Results 1 to 10 of about 363,849 (261)
Experimental training in molecular pharmacology education based on drug–target interactions [PDF]
Pharmacology Research & Perspectives, 2023 Introduction Drug development has been challenged by the dual drawbacks involving unpredictable disease outcomes and drug resistance, which has placed greater demands on pharmacology education.
Luna Ge +6 more
doaj +2 more sources
Molecular Pharmacology in Diabetes. [PDF]
Int J Mol SciThis Special Issue highlights the key molecules and molecular signaling pathways associated with diabetes and its multifaceted complications [...]
Reis F, Fernandes R.
europepmc +3 more sources
Molecular Pharmacology at the Crossroads of Precision Medicine [PDF]
Current Issues in Molecular BiologyMolecular pharmacology sits at the nexus of fundamental molecular science and therapeutic innovation [...]
Alina Crenguţa Nicolae +2 more
doaj +2 more sources
Molecular pharmacology of GPCRs. [PDF]
Br J Pharmacol, 2018 Linked ArticlesThis article is part of a themed section on Molecular Pharmacology of GPCRs. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.21 ...
Langmead CJ, Summers RJ.
europepmc +4 more sources
Artemisinin-Based Antimalarial Drug Therapy: Molecular Pharmacology and Evolving Resistance [PDF]
Tropical Medicine and Infectious Disease, 2019 The molecular pharmacology of artemisinin (ART)-based antimalarial drugs is incompletely understood. Clinically, these drugs are used in combination with longer lasting partner drugs in several different artemisinin combination therapies (ACTs). ACTs are
Laura E. Heller, Paul D. Roepe
doaj +2 more sources
Frontiers in Pharmacology, 2022 Positive allosteric modulation of the type 1 cannabinoid receptor (CB1R) has substantial potential to treat both neurological and immune disorders.
Asher L. Brandt +10 more
doaj +1 more source
Frontiers in Molecular Neuroscience, 2022 Ketamine, an N-methyl-D-aspartate (NMDA)-receptor antagonist, is a recently revitalized treatment for pain and depression, yet its actions at the molecular level remain incompletely defined.
Jenny J. Kim +8 more
doaj +1 more source
Cells, 2022 The dopamine transporter (DAT) is a member of the neurotransmitter:sodium symporter (NSS) family, mediating the sodium-driven reuptake of dopamine from the extracellular space thereby terminating dopaminergic neurotransmission.
Ciara Frances Pugh +3 more
doaj +1 more source
Неврология, нейропсихиатрия, психосоматика, 2021 Objective: to analyze the roles of undifferentiated connective tissue dysplasia (UCTD) in the development of cartilage and ligamentous apparatus diseases.Material and methods. This paper presents the results of analyzing the literature on fundamental and
I. Yu. Torshin +4 more
doaj +1 more source
Decoding the mechanisms of allostery
eLife, 2023 A complex interplay between structure, conformational dynamics and pharmacology defines distant regulation of G protein-coupled receptors.
Saif Khan, Cornelius Gati
doaj +1 more source